Search results
Results from the WOW.Com Content Network
However, there is an important lack of randomized clinical studies and recent guidelines (KDIGO 2017) have been recently released on the topic. Although it was previously considered, normalization of calcemia is not included in modern treatment goals since the advent of calcimimetics. [5]
Kidney Disease Improving Global Outcomes – KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease [58] A glomerular filtration rate (GFR) ≥ 60 mL/min/1.73 m 2 is considered normal without chronic kidney disease if there is no kidney damage present.
The functions of the kidney include maintenance of acid-base balance; regulation of fluid balance; regulation of sodium, potassium, and other electrolytes; clearance of toxins; absorption of glucose, amino acids, and other small molecules; regulation of blood pressure; production of various hormones, such as erythropoietin; and activation of vitamin D.
Introduced by the KDIGO in 2012, [13] specific criteria exist for the diagnosis of AKI. AKI can be diagnosed if any one of the following is present: Increase in SCr by ≥0.3 mg/dl (≥26.5 μmol/L) within 48 hours; or; Increase in SCr to ≥1.5 times baseline, which has occurred within the prior 7 days; or; Urine volume < 0.5 mL/kg/h for 6 hours.
Renal osteodystrophy has been classically described to be the result of hyperparathyroidism secondary to hyperphosphatemia combined with hypocalcemia, both of which are due to decreased excretion of phosphate by the damaged kidney.
"Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward". Kidney International. 85 (1): 49–61. doi: 10.1038/ki.2013.444. PMID 24284513. Co-author of textbook: “Chronic Kidney Disease: a practical guide to understanding and management”, ISBN 9780199549313
Accused UnitedHealthcare CEO killer Luigi Mangione spent his first night back in the Big Apple under the same NYC federal prison as disgraced rap mogul Sean "Diddy" Combs.
Andrew S. Levey (born September 16, 1950) is an American nephrologist who transformed chronic kidney disease (CKD) clinical practice, research, and public health by developing equations to estimate glomerular filtration rate (GFR) (renal function), and leading the global standardization of CKD definition and staging.